Chong Kun Dang Pharmaceutical Corp. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW4954.46 |
Market Cap |
KRW938.02 B |
Shares Outstanding |
10.37 M |
Public Float |
5.92 M |
Address |
8 Chungjeong-ro Seoul SL 03742 Korea, Republic Of |
Employees | - |
Website | http://www.ckdpharm.com |
Updated | 07/08/2019 |
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetic, antivirus, beta-blocking, anti-hyperlipidemia and others. The company was founded on November 2, 2013 and is headquartered in Seoul, South Korea. |